LONDON — Medicine was once a craft. Experienced doctors looked, listened and judged. Then came the thermometer, the stethoscope, the blood test and the scan, and medical practice became medical science: the same experienced judgement, now informed by objective readings. Today the Specialist Insurance Transformation Practice (SITP) publishes the evidence for the same transition in business.
Business Science applies the scientific method (observe, measure, predict, test, and prove or disprove) to the structural condition of a company. For the first time, the underlying health of a business can be measured with a validated system, its direction forecast with a stated accuracy rate, and the result backed by evidence tested to some of the most demanding standards in science.
At the centre of the discipline is the Structural Intelligence System. In plain terms, it reads whether a company is built to grow stronger over time or to quietly decay, and it does so before the financial results reveal which way the business is heading. It goes well beyond diagnosis. It places a company in one of a few clearly defined structural states, pinpoints the single thing most holding it back, and forecasts not only where the business is going but roughly when its own financial results will catch up and prove it, often years ahead of the numbers. It then sets out a costed, step-by-step plan to put right what it finds. And for an acquisition, it reads both companies and produces a defensible value for the deal, the same figure whoever is asking. These are the questions ordinary analysis cannot answer: is this company's strategy actually deliverable given the way it is built; will this acquisition create value or destroy it; what is really holding the business back, and what would it cost to fix.
The system has been tested against 1,057 real mergers and acquisitions, spanning 41 years and $10.11 trillion of deals, and it called the outcome correctly 99.8% of the time. It has then been held to the full validation battery that medicine uses to approve a diagnostic device and that physics uses to confirm a discovery, 19 tests in all, and on every one it does not merely meet the required standard but significantly surpasses it.
The era of reading a business, rather than guessing at it, has begun.
Why This Matters Now
Three shifts make this announcement commercially significant.
Most M&A is flying blind. Global M&A advice earns over $40 billion in fees a year, yet between 70% and 90% of deals fail to deliver the savings and synergies promised. The reason is that the advice rests on financial models that measure what a business earns, not whether the way it is built can sustain those earnings once two companies are combined. The Structural Intelligence System reads that compatibility directly, at 99.8% accuracy. Most of those failures are avoidable.
AI is splitting companies into winners and losers. Every board is now spending on artificial intelligence. The system tells apart two kinds of spending that look identical on paper: AI that compounds, where each use makes the company's knowledge deeper and the next use better, and AI that is merely bolted on as a cost. One builds a lasting advantage; the other builds overhead. The gap is invisible in the accounts until it is too late to close. The system shows a board which side of that line it is on.
Insurance is at a turning point, and the timing is exact. Blueprint Two, the London market's central modernisation programme, has slipped to 2028, so 86% of firms are pressing ahead on their own and 78% of brokers now treat an insurer's technology as a deciding factor in where they place business. On top of that, Lloyd's has just extended its Core Data Record to treaty reinsurance (CDR v3.3, published 18 May 2026), adding 47 new data fields, most of which carriers' existing systems were never built to produce. Boards need to know, objectively, where they stand. SITP has already read the entire London market as a single cohort.
John Bowers, Strategic Advisory Principal - Strategy, Technology and Artificial Intelligence:
"The validation of a new science could not come at a more appropriate time for our initial market, insurance. With the market softening, the introduction of AI, and the latest changes to the Lloyd's CDR, now more than ever the boards of these carriers need an unbiased, structural understanding of their ability to operate and navigate the major changes the market is already starting to feel."
What the Evidence Shows
Those 19 tests are the validation battery that medicine, physics, epidemiology and quantitative finance use to prove a result before it is trusted. The system passed every one. Twelve beat the published standard for "excellent" in their field, five reached the maximum score possible, and two have no published precedent at this scale in any applied field. The headline results:
Statistical certainty far beyond a scientific discovery. In physics, a finding counts as a discovery at a confidence score of 5.0, the bar CERN cleared to confirm the Higgs boson. Drug approval needs only 1.96. The system scores 31.16, more than six times the discovery threshold.
Perfect objectivity. Give the same company to two independent assessors and they reach exactly the same result, every time. That is the highest consistency a test can achieve. For comparison, expert radiologists reading the same scans agree 60% to 80% of the time, and psychiatrists 40% to 70%.
224 destructive cases called correctly, with no misses. Every time the system has flagged a company's structure as value-destroying, it has been right, across 224 cases without a single exception.
It holds everywhere. Across 20 industries, accuracy never fell below 96.3%. Across five decades, it showed no decline. Across six continents, it was 100% in every region. Structure behaves the same way regardless of sector, country or era.
It values deals, not just judges them. Tested against 20 major acquisitions worth $536.9 billion, the system's valuation model called the direction right every time. Buyers who fixed the structural problems it identified added $33.1 billion of value on average; those who ignored them destroyed $26.8 billion.
Who Benefits
Boards weighing an acquisition get a verdict on the deal before they commit: whether the promised synergies are realistically achievable, whether the two companies fit, and what fixing any mismatch will cost. It is a reading from a tested system, not an opinion.
Private equity firms can judge a target on how it is built, not just on its recent figures. A business can look healthy in a good market and still be set up to decay when conditions turn. The system reads that, and estimates when the financials will catch up with the reality.
Insurance carriers receive a structural read across nine dimensions: which of four scenarios they fall into, what is really holding them back, and a costed, sequenced plan to address it. 66 London market carriers have already been assessed, each report written for a specific audience, from the Chief Executive to the Chief Underwriting Officer.
Brokers can see which carriers are getting stronger and which are exposed, intelligence that bears directly on where they place business.
Consultancies and systems integrators can build the system into their own work, so every engagement opens with a measured diagnosis rather than a pitch. Two global systems integrators are already in talks to do exactly that.
How This Changes Business Beyond M&A
The M&A evidence is the most dramatic, but the discipline is bigger than deals. The system reads whether any company is built to compound its advantages or erode them, and that matters wherever structure decides the outcome.
It makes the invisible balance sheet visible. A company's real strengths, its knowledge, its governance, its ability to learn and improve, appear on no financial statement, yet they decide whether today's profits last. Business Science measures them.
It gives strategy a measurement standard. Consulting runs on judgement and reputation. Its frameworks, from Porter's Five Forces to the Balanced Scorecard, were landmarks, but none came with a stated accuracy rate or was tested against a predictive dataset. Business Science adds exactly that: a measured reading instead of a competing opinion.
It turns advisory from "trust me" into "here is the evidence." This is the same shift medicine made. The thermometer and the scan did not replace the doctor; they made the doctor better. The Structural Intelligence System does the same for the adviser. The consultant still judges, but the judgement now rests on a reading validated at 99.8% accuracy. The consultant is no longer guessing. The consultant is reading.
Two things follow that no rival can currently match. First, because the system has a proven accuracy rate, SITP can stand behind its verdict on a deal in a way no opinion-based firm can. Second, because the reading is the same whoever commissions it, both sides of a transaction can work from one shared set of facts rather than two opposing pitches.
What SITP Does
SITP delivers structural intelligence as a principal-led service, from the first reading through to building the fix. The same team that diagnoses the problem designs the solution and delivers it. There is no handoff.
The whole market, already read. SITP has assessed all 66 significant London market carriers as one cohort, mapping not only each carrier's structural condition but the actual technology it runs and how exposed that leaves it. Two assessments are available to carriers, brokers and investors today. The structural assessment is a full read of a carrier across nine dimensions, naming the single thing most holding it back and setting out a costed plan to address it, written for whichever leader needs it. The CDR readiness assessment is a field-by-field verdict on whether a carrier's systems can actually meet the new Lloyd's treaty data standard, and what it will take to close the gap. SITP's analysis finds that no platform sold in the London market today produces the new computed fields out of the box, which means almost every carrier has work to do and few yet realise it.
This is the beginning, not the extent. The platform already holds structural readings on more than 500 businesses across several markets. Over the coming months the practice will give the US excess and surplus market, Bermuda, continental Europe, and life and pensions the same full-cohort treatment the London market has had: every significant carrier in every major market, read structurally, before anyone asks.
M&A intelligence. For a transaction, the system produces a structurally derived value for the target, reading both sides, pricing the risk, and standing behind the verdict.
Delivery. Once the reading finds what is holding a business back, the practice designs and delivers the fix, at principal level. Its evidence is its own current work: the entire London market read as a single cohort of 66 carriers, each with its technology estate mapped, and a field-level CDR readiness assessment no competitor can produce. The principals bring recognition earned across two decades in the market, including Everest Group Leader status, the ACORD Vanguard Award, and validated Blueprint Two Phase 1 and 2 delivery as one of the few teams in the world to have done it.
The practice comprises John Bowers (Strategic Advisory Principal - Strategy, Technology and Artificial Intelligence), Paul McGee (Commercial and Strategy) and Daniel Elliott-Taylor (Engineering and Architecture). The Financial Signal Lag framework is the work of Paul McGee.
John Bowers, Strategic Advisory Principal - Strategy, Technology and Artificial Intelligence:
"Every consultant in this market gives you an opinion. We give you a reading. It is the difference between a doctor who says 'I think you have pneumonia' and one who says 'the scan shows it.' Both may be right; only one has the evidence. We have spent twenty years building this system, testing it against more than a thousand deals and against nineteen scientific standards. The result is that we can stand behind our verdict. No one else in this market can say that."
Verification
The evidence base is not a sample; it is comprehensive, and it is recorded rather than asserted. The M&A dataset covers 1,057 transactions and $10.11 trillion of deal value over 41 years, from the buyout era of the 1980s to the AI-driven megadeals of 2025, across 186 industries and six continents. A second, separate dataset covers 1,003 companies over six decades, including 281 structural failures, with no exceptions to the system's predictions. Every prediction is timestamped and tracked against the outcome as it arrives, so the accuracy rate is a measured record, not an estimate. The full 19-test programme, its results, and the underlying methodology are documented in a reference paper available to qualified journalists and reviewers on request. Every figure can be examined against the evidence that produced it.
About SITP
The Specialist Insurance Transformation Practice is a principal-led advisory firm working in London Market specialty insurance and property and casualty. It is the commercial home of Business Science, the application of scientific method to the structural intelligence of a company. Company No. 17134978. sitp.london.
Contact
John Bowers · john@sitp.london · sitp.london
Notes to Editors
1. The Structural Intelligence System, its frameworks and the discipline of Business Science are the original intellectual property of John Bowers, protected under the Copyright, Designs and Patents Act 1988, with UK IPO trademark filings registered. The Financial Signal Lag framework is the work of Paul McGee.
2. The 19-test validation reference document is available to qualified journalists and scientific reviewers on request.
3. The platform at sitp.london is a live production system. All figures are current as of May 2026.
4. The practice welcomes independent audit of any result claimed here.
© 2026 John Bowers · Specialist Insurance Transformation Practice Strategy · Execution · Delivery